Homrich & Berg’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $1.75M | Sell |
29,667
-1,494
| -5% | -$98.4K | 0.04% | 163 |
|
|
2021
Q2 | $2.08M | Buy |
31,161
+1,111
| +4% | +$72.4K | 0.05% | 148 |
|
|
2021
Q1 | $1.9M | Sell |
30,050
-1,959
| -6% | -$122K | 0.05% | 145 |
|
|
2020
Q4 | $1.99M | Sell |
32,009
-2,081
| -6% | -$128K | 0.06% | 120 |
|
|
2020
Q3 | $2.06M | Buy |
34,090
+5,099
| +18% | +$307K | 0.07% | 89 |
|
|
2020
Q2 | $1.71M | Buy |
28,991
+2,651
| +10% | +$159K | 0.07% | 91 |
|
|
2020
Q1 | $1.47M | Sell |
26,340
-2,852
| -10% | -$174K | 0.08% | 87 |
|
|
2019
Q4 | $1.87M | Buy |
29,192
+3,774
| +15% | +$216K | 0.09% | 93 |
|
|
2019
Q3 | $1.29M | Buy |
25,418
+638
| +3% | +$30K | 0.07% | 127 |
|
|
2019
Q2 | $1.12M | Buy |
24,780
+2,176
| +10% | +$101K | 0.06% | 136 |
|
|
2019
Q1 | $1.08M | Sell |
22,604
-471
| -2% | -$23.5K | 0.06% | 129 |
|
|
2018
Q4 | $1.2M | Buy |
23,075
+957
| +4% | +$51.4K | 0.07% | 107 |
|
|
2018
Q3 | $1.37M | Buy |
22,118
+6,777
| +44% | +$402K | 0.08% | 98 |
|
|
2018
Q2 | $849K | Buy |
15,341
+65
| +0.4% | +$3.51K | 0.06% | 139 |
|
|
2018
Q1 | $966K | Buy |
15,276
+5,605
| +58% | +$361K | 0.07% | 132 |
|
|
2017
Q4 | $593K | Buy |
9,671
+418
| +5% | +$26.1K | 0.04% | 188 |
|
|
2017
Q3 | $590K | Buy |
9,253
+294
| +3% | +$17.2K | 0.05% | 172 |
|
|
2017
Q2 | $499K | Sell |
8,959
-2,925
| -25% | -$159K | 0.04% | 169 |
|
|
2017
Q1 | $646K | Sell |
11,884
-1,307
| -10% | -$71.7K | 0.06% | 141 |
|
|
2016
Q4 | $771K | Sell |
13,191
-614
| -4% | -$33.6K | 0.07% | 111 |
|
|
2016
Q3 | $744K | Sell |
13,805
-4,171
| -23% | -$268K | 0.07% | 110 |
|
|
2016
Q2 | $1.32M | Buy |
17,976
+1,383
| +8% | +$97.7K | 0.13% | 56 |
|
|
2016
Q1 | $1.06M | Sell |
16,593
-1,578
| -9% | -$99.5K | 0.1% | 72 |
|
|
2015
Q4 | $1.25M | Buy |
18,171
+671
| +4% | +$44.3K | 0.11% | 67 |
|
|
2015
Q3 | $1.04M | Sell |
17,500
-3,231
| -16% | -$205K | 0.11% | 77 |
|
|
2015
Q2 | $1.38M | Sell |
20,731
-1,716
| -8% | -$113K | 0.13% | 65 |
|
|
2015
Q1 | $1.45M | Buy |
22,447
+604
| +3% | +$37.8K | 0.14% | 62 |
|
|
2014
Q4 | $1.29M | Buy |
21,843
+4,811
| +28% | +$271K | 0.13% | 68 |
|
|
2014
Q3 | $872K | Buy |
17,032
+1,060
| +7% | +$52.9K | 0.09% | 97 |
|
|
2014
Q2 | $775K | Sell |
15,972
-7,072
| -31% | -$349K | 0.09% | 93 |
|
|
2014
Q1 | $1.2M | Buy |
23,044
+6,131
| +36% | +$326K | 0.16% | 61 |
|
|
2013
Q4 | $899K | Buy |
16,913
+102
| +0.6% | +$5.2K | 0.13% | 71 |
|
|
2013
Q3 | $778K | Sell |
16,811
-441
| -3% | -$19.4K | 0.12% | 77 |
|
|
2013
Q2 | $771K | Buy |
+17,252
| New | +$749K | 0.14% | 64 |
|
Other funds holding BMY
Homrich & Berg's BMY Position: Q3 2021 in Review
Homrich & Berg reduced its Bristol-Myers Squibb (BMY) stake by 4.8% in Q3 2021, selling an estimated $98.4K and leaving 29,667 shares worth $1.75M. The position accounts for 0.04% of the portfolio, ranked #163.
Homrich & Berg first reported a position in BMY in Q2 2013 and has held it in 34 quarters since. The position peaked at $2.08M in Q2 2021. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.
- Homrich & Berg held 29,667 shares of Bristol-Myers Squibb worth $1.75M as of Q3 2021.
- Homrich & Berg sold 1,494 Bristol-Myers Squibb shares in Q3 2021, an estimated $98.4K.
- Bristol-Myers Squibb made up 0.04% of Homrich & Berg's portfolio in Q3 2021, its #163 holding.
- Homrich & Berg first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 34 quarters since.
- Homrich & Berg's Bristol-Myers Squibb position peaked at $2.08M in Q2 2021.
- 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.
Based on Homrich & Berg's 13F filing for Q3 2021, filed 8 Dec 2021.